pharma · Chronic Spontaneous Urticaria (CSU) · Asthma · SPRY
Ars Pharmaceuticals Irl
Ars Pharmaceuticals Irl Limited
Ars Pharmaceuticals Irl is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker SPRY. Primary therapeutic focus areas include Chronic Spontaneous Urticaria (CSU), Asthma, Urticaria, Upper
San Diego, USA HQ
187 Employees
Public company Type
SPRY · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Employees
- 187
- Programs
- 8
- Drugs
- 7
- Patents
- 0
ARS-1
Phase 2 · small molecule · Asthma
ARS-1 for Asthma is a Phase 2 program (small_molecule) at Ars Pharmaceuticals Irl Limited with 1 ClinicalTrials.gov record(s).
Internal code EPI A01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Ars Pharmaceuticals Irl Limited
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Asthma
- Status
- completed
- Trials
- 1